Regulation and market access
Compare licensing categories, permitted product classes, reporting obligations, and the date on which each rule or dataset was valid.
DIGITAL INFRASTRUCTURE ACROSS THE CANNABIS VALUE CHAIN
From operational records to market analysis
Regulated cultivation, laboratory work, logistics, compliance, and digital services all depend on data created for different purposes. Understanding how these records are created, connected, and governed identifies operational requirements and the limits of comparisons between organizations or jurisdictions.
Research and Markets reports an estimated global cannabis technology market of US$5.6 billion in 2025 and a projection of US$28.3 billion by 2032 in its Cannabis Technology - Global Strategic Business Report (August 2026). These are the publisher's estimates and forecast, not independently verified market totals.
Seed-to-sale systems, laboratory information management, geospatial monitoring, controlled-environment agriculture, AI-assisted curation, and molecular knowledge tools all depend on well-structured records that keep species identity, chemical profiles, provenance, regulation, and scientific interpretation auditable.
COMPARING JURISDICTIONS
Regulatory and operational differences across jurisdictions
Licenses, permitted products, reporting duties, and research policy vary across jurisdictions. A useful comparison therefore separates regulated commercial activity, industrial hemp, pharmaceutical development, and illicit-market indicators before placing numbers or technologies side by side.
Technology across the value chain
Track cultivation systems, laboratory informatics, traceability, quality control, manufacturing, logistics, and data interoperability as distinct capabilities.
Biotechnology and requirements for pharmaceutical development
Keep preclinical evidence, clinical research, quality and CMC requirements, approved uses, and commercial claims in separate analytical layers.
Inspect the institutional sources Market data · public health · clinical quality · global context
- United Nations Sustainable Development Goals — canonical definitions for the 17 Goals and 169 targets; this framework does not assign an official Cannabis impact score.
- United Nations system position on drug policy — balanced, evidence-based, human-rights-based, and development-oriented principles for policy analysis.
- WHO and UNODC prevention standards — institutional evidence framework for prevention programs; program outcomes must be evaluated rather than assumed.
- Health Canada market data — regulated inventory, sales, product classes, licensed area, reporting period, and revision status.
- European Drug Report 2026: Cannabis — European drug-market and public-health indicators that must not be treated as equivalent to legal commercial-market data; updated 9 June 2026, DOI 10.2810/8266522.
- FDA quality guidance for clinical research — pharmaceutical quality and research requirements for cannabis and cannabis-derived compounds.
- UNODC World Drug Report — global drug-policy and illicit-market context, maintained as a separate evidence class.
- Riboulet-Zemouli et al. (2019), Cannabis & Sustainable Development, FAAAT, ISBN 979-10-97087-34-0 — civil-society policy report retained as a proposed ODS mapping, not as United Nations validation.
REGULATORY MAP | BRAZIL · ANVISA
How the 2026 RDCs organize research, cultivation, and products
The resolutions cover different stages and actors: control lists, research, medicinal cultivation, associations, manufacturing, imports, and product circulation. The summaries below help locate each topic; always consult Anvisa's current texts for legal or operational decisions.
RDC 1.011/2026 control lists
Controlled-substance lists
Updates the lists of substances subject to special control under Portaria SVS/MS 344/1998, including the relevant addenda for the 2026 cannabis regulatory package.
RDC 1.012/2026 research
Cultivation exclusively for research
Defines requirements for eligible legal entities cultivating Cannabis sativa L. exclusively for research under special authorization, with security, control, documentation, and traceability obligations.
RDC 1.013/2026 cultivation
Medicinal cultivation up to 0.3% THC
Defines cultivation of Cannabis sativa L. with total THC at or below 0.3% in dry inflorescences, exclusively for medicinal, pharmaceutical, and research purposes, under authorization, inspection, security, control, and traceability requirements.
RDC 1.014/2026 associations
Non-profit patient associations
Creates a specific instrument for non-profit patient associations, with monitoring, quality control, and traceability through dispensing.
RDC 1.015/2026 authorization
Manufacture and import of medicinal products
Updates the sanitary-authorization framework for manufacturing and importing cannabis products for human medicinal use, replacing the previous RDC 327/2019 framework subject to its transition rules.
RDC 1.023/2026 complementary update
Labeling, dispensing, classification, and export
A later complementary act aligns labeling, dispensing, classification, and export rules for cannabis products and active pharmaceutical ingredients produced in Brazil.
BIOECONOMY · EVIDENCE · IMPACT
Demonstrated impact requires evidence beyond technical potential
A use of plant material can support a market claim only when performance, cost, regulation, and environmental effects are measured within a defined supply chain. Market growth indicates economic activity; by itself, it does not demonstrate sustainability or social benefit.
| Pathway | Possible market association | Comparable data required | Claim boundary |
|---|---|---|---|
| Fibers and biomaterials | Textiles, paper, composites, insulation, construction, and product-design supply chains. | Feedstock grade, yield, processing route, specifications, price, durability, transport, and life-cycle inventory. | “Plant-based” or carbon stored during growth does not by itself establish lower total impact. |
| Biomass and energy | Residue management, heat, gas, liquid fuels, biochar, and distributed conversion technologies. | Available residue, moisture, conversion efficiency, net energy, emissions, coproducts, and infrastructure cost. | Renewable feedstock is not synonymous with sustainable or commercially viable energy. |
| Remediation services | Site assessment, controlled cultivation, environmental monitoring, biomass treatment, and restoration services. | Contaminant and site definition, removal performance, exposure controls, biomass destination, cost, and verification. | Contaminated biomass may require controlled disposal and must not automatically enter food, feed, or consumer supply chains. |
| Health, research, education, and workforce | Clinical and public-health research, laboratory quality, prevention and harm-reduction programs, professional training, compliance, and data services. | Population, intervention, jurisdiction, access, cost, effectiveness, equity, adverse outcomes, and evaluation period. | These outcomes belong to programs and institutions, not to the commodity or species as an intrinsic market benefit. |
01
Capability
A material, process, service, or program is technically defined.
02
Measured output
Performance, quality, cost, and limitations are documented.
03
Governed offering
Jurisdiction, standards, traceability, and intended use are explicit.
04
Comparable indicators
Market and impact indicators share definitions, periods, and units.
Read the biological and methodological starting point on the Cannabis species page . Public-health interpretation should also consult the EUDA guide to health and social responses.
LEARN TO READ NORMALIZED SERIES
Compare normalized trajectories over time
Normalization gives every series the same starting point, making it possible to compare how each trajectory changes relative to the others. This example uses local illustrative values to teach the method; it does not display historical or live quotations. Market analysis would require each series to identify its source, period, currency, and update date.
EXAMPLE SERIES | RELATIVE CHANGE
Normalized example series for selected tickers
The chart aligns each asset to the same starting index so visitors can inspect relative movement within the example dataset and its average line.
Open methodology, formulas, and source status Normalization · data processing · limitations · interpretation
ILLUSTRATIVE SERIES | DATA PROCESSING
How example values become lines in the chart
The legacy notebook REST API - Stocks and Quotes showed the basic workflow: choose the cannabis-company tickers, retrieve closing prices, organize them by date, transform each company into the same baseline, and then draw one line per asset. The method compares movement from each starting point. The current chart applies that method to illustrative values, not retrieved quotes.
Choose the tickers
We start with the selected cannabis companies:
CGC, ACB, TLRY,
CRON, GTBIF, CURLF,
and AVCNF. Each ticker becomes one colored
line.
Inspect the example values
The local example provides a sequence of values for each
ticker. If one series moves from 5.20 to
6.10, those values are the raw material for the
line.
Create a baseline
The first example value becomes 1.00. Every
later value is divided by that first value, so the chart
shows relative change instead of raw values.
Draw the line
Each normalized value becomes a point. When the browser connects the points, the visitor sees whether that asset moved above, below, or near its starting baseline.
Example calculation
If the first value is 5.20 and a later value is
6.10, the plotted value is
6.10 / 5.20 ≈ 1.17. That means the series is
about 17% above its own starting point in this example.
Average portfolio line
The portfolio line is the arithmetic average of the normalized values for all visible series at the same example point. It acts as a simple reference line for the basket.
How the example points are generated
The chart uses local illustrative values. The controls select 30 to 180 simulated points, not days. The browser interpolates between four example values per ticker and adds a small synthetic variation for display.
ALGORITHM | HOW THE CHART IS BUILT
What the formulas mean in plain language
Each example series starts at 1.00. Later values
are measured against that starting point, and the basket line
averages the normalized values at each simulated point.
normalized_value = example_value / first_visible_value
example_change_percent = ((last_value - first_value) / first_value) * 100
basket_line = average(normalized_values_at_same_point)
In the visual, a line above 1.00 means the asset
rose relative to its first example value. A line below
1.00 fell relative to that baseline. This
describes the simulated dataset, not a historical stock
movement.
DATA STATUS | ILLUSTRATIVE VALUES
Source and limits of the example
The example contains illustrative series, not verified historical prices or live quotations. Their normalized changes describe the simulated dataset. A market analysis would require a documented source, period, currency, update date, and comparability criteria for each series.
Technical documentation · planned market-data integration
The chart uses the embedded illustrative dataset. When that copy is unavailable, it loads bioinfo_cannabis/data/market-portfolio.json. The separate scripts/market_portfolio_builder.py prepares JSON outside the browser.
The API contract is a proposal; these routes are planned and are not available through this static module: /api/v1/market/tickers and /api/v1/market/history?t=CGC,ACB,TLRY&days=30. Any implementation would need source metadata, timestamps, a cache policy, error handling, and a visible disclaimer.
PROFESSIONAL DEVELOPMENT
Job requirements as references for study and portfolio projects
Explore roles observed in 2026, identify recurring skills and tools, and turn those requirements into study topics and portfolio projects.
The sample preserves the reported salary and context of each record. For current opportunities, follow the companies and review available roles on LinkedIn.
Explore technology and data careers
Roles by companySkills & toolsProgramming languagesStudy plan